Burnet partners with Atomo to develop Australia’s first syphilis self-test
Hepatitis C treatment in pharmacies could boost diagnosis and cure rates
Urgent and equitable action needed to prevent mpox becoming the next pandemic emergency
Cost-effective solutions to prevent and treat postpartum haemorrhage
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Stellabody®: A novel hexamer-promoting mutation for improved IgG potency
Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extrac...
20-year trends in Australian methamphetamine-related deaths, 2001-2020.
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Aus...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Harney B, Doyle J, Stoové M, Hellard M, Winter R
Journal Sexually transmitted diseases
Published 01 Nov 2021
Volume 48
ISSUE 10
Pagination e153
DOI 10.1097/OLQ.0000000000001532